Healthcare Services

A Significant Growth Driver for the Lisinopril Market Is the Rising Cardiovascular Disease Rates Drive Expansion Of Lisinopril Market

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Lisinopril Market Evolve From 2026 To 2030?

The lisinopril market size has exhibited strong growth in recent years. It is anticipated to expand from $1.87 billion in 2025 to $1.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. This historic growth can be attributed to several factors, including the increasing incidence of hypertension, widespread clinical acceptance of ACE inhibitors, a growing aging population, early adoption in heart failure treatment, and the expansion of primary healthcare access.

The lisinopril market size is anticipated to undergo substantial growth in the upcoming years, with projections indicating it will reach $2.47 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period is primarily driven by an increasing burden of cardiovascular diseases, a rising demand for affordable generic drugs, a heightened focus on preventive cardiac care, the expansion of treatment for diabetic kidney disease, and increased healthcare spending dedicated to chronic disease management. Significant trends expected in this period encompass the rising prevalence of hypertension and cardiovascular disorders, an growing reliance on ACE inhibitors as first-line therapy, an expansion in generic lisinopril prescriptions, its increasing utilization in post-heart attack management, and an improvement in long-term treatment adherence within chronic care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Lisinopril Market?

The expanding occurrence of cardiovascular ailments is projected to boost the expansion of the lisinopril market in the future. Cardiovascular diseases (CVDs) are defined as various conditions impacting the heart and circulatory system. This rise in CVD prevalence stems from multiple contributors, including an expanding and aging global population, various risk factors, and insufficient application of established prevention and treatment methods. Lisinopril aids in managing these conditions mainly by decreasing blood pressure and alleviating stress on the heart and kidneys. The medication achieves this by blocking angiotensin II production, promoting blood vessel relaxation, lowering blood volume, and safeguarding vital organs from harm. For example, data from May 2024, released by the Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, indicated that ischemic heart diseases caused 5,302 deaths, a modest rise from 5,290 deaths recorded in 2022. Consequently, the increasing occurrence of cardiovascular diseases is propelling the expansion of the lisinopril market.

Which Segment Areas Are Covered In The Lisinopril Market Analysis?

The lisinopril market covered in this report is segmented –

1) By Brand: Prinivil, Zestril, Other Brands

2) By Disease: Hypertension, Heart Failure, Heart Attack

3) By Dosage: Tablet, Liquid

4) By End-Users: Hospitals, Specialty Clinics

Subsegments:

1) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil

2) By Zestril: Different Dosage Forms, Generic Versions Of Zestril

3) By Other Brands: International Brand Variants, Combination Drug Formulations

Which Global Companies Are Actively Competing In The Lisinopril Market?

Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zydus Cadila Healthcare Ltd., Hetero Ltd., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Mylan Pharmaceuticals Inc., Accord Healthcare Ltd., Sandoz International GmbH

Read the full lisinopril market report here:

https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

What Are The Leading Geographic Regions In The Lisinopril Market?

North America was the largest region in the lisinopril market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lisinopril Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16465&type=smp

Browse Through More Reports Similar to the Global Lisinopril Market 2026, By The Business Research Company

Liraglutide Global Market Report

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Lithium Global Market Report

https://www.thebusinessresearchcompany.com/report/lithium-global-market-report

Lithium Ion Li Ion Batteries Global Market Report

https://www.thebusinessresearchcompany.com/report/lithium-ion-li-ion-batteries-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795